Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study

Monitoring of Immune Responses Following Mogamulizumab-Containing Treatment in Patients with Adult T-Cell Leukemia-Lymphoma (ATL) (MIMOGA) is a multicenter prospective observational study to establish the most effective and safe treatment strategy using mogamulizumab for ATL patients (UMIN000008696)...

詳細記述

保存先:
書誌詳細
出版年:Blood Adv
主要な著者: Yonekura, Kentaro, Kusumoto, Shigeru, Choi, Ilseung, Nakano, Nobuaki, Ito, Asahi, Suehiro, Youko, Imaizumi, Yoshitaka, Yoshimitsu, Makoto, Nosaka, Kisato, Ohtsuka, Eiichi, Hidaka, Michihiro, Jo, Tatsuro, Sasaki, Hidenori, Moriuchi, Yukiyoshi, Ogata, Masao, Tatetsu, Hiro, Ishitsuka, Kenji, Miyazaki, Yasushi, Ueda, Ryuzo, Utsunomiya, Atae, Ishida, Takashi
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2020
主題:
Immunobiology and Immunotherapy
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594399/
https://ncbi.nlm.nih.gov/pubmed/33091125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003053
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料